News from hospira, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 19, 2015, 06:07 ET

Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

 Data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first approved biosimilar monoclonal antibody...

Feb 16, 2015, 04:55 ET

Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets

 Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch of the first biosimilar...

Feb 12, 2015, 07:30 ET

Hospira Reports Fourth-Quarter and Full-Year 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Feb 10, 2015, 09:15 ET

Pfenex And Hospira Announce Collaboration To Develop And Commercialize Proposed LUCENTIS® Biosimilar

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc.,...

Feb 09, 2015, 17:11 ET

Hospira Cancels Previously Scheduled Conference Call to Discuss Fourth-Quarter and Full-Year 2014 Results

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today...

Jan 29, 2015, 12:41 ET

Hospira to Host Conference Call for Fourth-Quarter 2014 Results and 2015 Projections

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, will...

Jan 20, 2015, 10:30 ET

Hospira Receives FDA Clearance for Plum 360™ Infusion System

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company...

Jan 12, 2015, 09:00 ET

Hospira Submits New Biologics License Application to U.S. FDA for Proposed Epoetin Alfa Biosimilar

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in...

Jan 08, 2015, 09:00 ET

Hospira Announces Significant Progess On Global Device Strategy

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today unveiled significant progress on...

Dec 30, 2014, 09:01 ET

Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject™(diclofenac sodium) Injection

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has...

Dec 19, 2014, 16:30 ET

Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will...

Dec 19, 2014, 14:45 ET
Hospira Foundation announces The Leukemia & Lymphoma Society as winner of $100,000 (Mission: Care)2 grant.

Hospira Foundation Announces The Leukemia & Lymphoma Society as Winner of $100,000 (Mission: Care)2 Grant

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced that The Leukemia & Lymphoma Society (LLS) was selected...

Dec 02, 2014, 15:51 ET
Hospira Foundation announces 10 recipients of (Mission: Care)2 Grant Challenge and launches video contest to decide winner of an additional $100,000 grant.

Hospira Foundation Announces 10 Recipients of (Mission: Care)2 Grants and Initiates Next Phase of Challenge

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced the 10 recipients of the initial grants for (Mission: Care)2,...

Nov 17, 2014, 10:30 ET

Hospira Mourns Passing of Founding Board Member Dr. Connie R. Curran

 The board of directors and employees of Hospira, Inc. (NYSE: HSP)  today expressed their deepest sorrow over the loss of Connie  R....

Nov 06, 2014, 07:30 ET

Hospira Reports Third-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third...

Nov 05, 2014, 16:08 ET

Hospira Announces U.S. Launch of Generic Paricalcitol Injection

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol...

Oct 06, 2014, 10:30 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira to Host Conference Call for Third-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss...

Oct 02, 2014, 15:39 ET
Apply now for the 2014 Hospira Foundation Grant Challenge online at Hospira.com/MissionCare2. (PRNewsFoto/The Hospira Foundation)

Hospira Foundation Announces Launch of (Mission: Care)2 Grant Challenge in Honor of 10th Anniversary

 The Hospira Foundation, the philanthropic arm of Hospira, Inc., today announced the launch of (Mission: Care)2, the 2014 Hospira Foundation...

Aug 15, 2014, 13:00 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira to Present at the Morgan Stanley Global Healthcare Conference

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will...

Jul 30, 2014, 07:30 ET
Like the name Hospira, the logo is unique, differentiating and contemporary. The arc highlights the word "spira" in the name, reinforcing Hospira's aspiration to be the world's leading hospital products provider and highlighting the spirit and inspiration of the employees that guide the company. (PRNewsFoto)

Hospira Reports Second-Quarter 2014 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second...